Emicizumab and thrombosis: The story so far

被引：55

作者：

Makris, Michael ^{[1
,2
]}

Iorio, Alfonso ^{[3
]}

Lenting, Peter J. ^{[4
]}

机构：

[1] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England

[2] Royal Hallamshire Hosp, Sheffield Haemophilia & Thrombosis Ctr, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England

[3] McMaster Univ, Dept Epidemiol & Biostat, Hamilton, ON, Canada

[4] Univ Paris Sud, INSERM, U1176, Le Kremlin Bicetre, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2019年 / 17卷 / 08期

关键词：

HEMOPHILIA-A; THROMBOCYTOPENIC PURPURA; PROPHYLAXIS; REGISTRY;

D O I：

10.1111/jth.14556

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1269 / 1272

页数：4

共 12 条

[1]

Flommersfeld S, 2019, GTH 2019 M BEL FEBR

[2] Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) [J].

Knoebl, P. ;

Marco, P. ;

Baudo, F. ;

Collins, P. ;

Huth-Kuhne, A. ;

Nemes, L. ;

Pellegrini, F. ;

Tengborn, L. ;

Levesque, H. ;

Aspoek, G. ;

Heistinger, M. ;

Knobl, P. ;

Makipernaa, A. ;

Andre, H. ;

Aouba, A. ;

Bellucci, Sylvia ;

Beurrier, P. ;

Borg, J. Y. ;

Darnige, L. ;

Devignes, J. ;

D'Oiron, R. ;

Gautier, P. ;

Gay, V. ;

Girault, S. ;

Gruel, Y. ;

Guerin, V. ;

Hezard, N. ;

Khellaf, M. ;

Koenig, M. ;

Lifermann, F. ;

Marlu, R. ;

Ninet, Jacques ;

Peynet, J. ;

Quemeneur, T. ;

Rothschild, C. ;

Schleinitz, N. ;

Sigaud, M. ;

Trouillier, S. ;

Voisin, S. ;

Giebl, A. ;

Holstein, K. ;

Loreth, R. M. ;

Steigerwald, U. ;

Tiede, A. ;

Theodossiades, G. ;

Radvanyi, G. ;

Schlammadinger, A. ;

Barillari, G. ;

Pasca, S. ;

Baudo, F. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) :622-631

[3] Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases [J].

Knoebl, Paul ;

Sperr, Wolfgang R. ;

Schellongowski, Peter ;

Staudinger, Thomas ;

Jilma-Stohlawetz, Petra ;

Quehenberger, Peter ;

Koder, Silvia ;

Ay, Cihan ;

Gleixner, Karoline V. .

BLOOD, 2018, 132

[4] Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII? [J].

Lenting, Peter J. ;

Denis, Cecile V. ;

Christophe, Olivier D. .

BLOOD, 2017, 130 (23) :2463-2468

[5]

Levy GG, 2019, J THROMB HAEMOST, DOI [10.1111/jth.14527, DOI 10.1111/JTH.14527]

[6] Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors [J].

Mahlangu, J. ;

Oldenburg, J. ;

Paz-Priel, I. ;

Negrier, C. ;

Niggli, M. ;

Mancuso, M. E. ;

Schmitt, C. ;

Jimenez-Yuste, V. ;

Kempton, C. ;

Dhalluin, C. ;

Callaghan, M. U. ;

Bujan, W. ;

Shima, M. ;

Adamkewicz, J. I. ;

Asikanius, E. ;

Levy, G. G. ;

Kruse-Jarres, R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (09) :811-822

[7]

Mariotte E, 2016, LANCET HAEMATOL, V3, pE237, DOI [10.1016/S2352-3026(16)30018-7, 10.1016/s2352-3026(16)30018-7]

[8] Emicizumab Prophylaxis in Hemophilia A with Inhibitors [J].

Oldenburg, Johannes ;

Mahlangu, Johnny N. ;

Kim, Benjamin ;

Schmitt, Christophe ;

Callaghan, Michael U. ;

Young, Guy ;

Santagostino, Elena ;

Kruse-Jarres, Rebecca ;

Negrier, Claude ;

Kessler, Craig ;

Valente, Nancy ;

Asikanius, Elina ;

Levy, Gallia G. ;

Windyga, Jerzy ;

Shima, Midori .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :809-818

[9] Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study [J].

Pipe, Steven W. ;

Shima, Midori ;

Lehle, Michaela ;

Shapiro, Amy ;

Chebon, Sammy ;

Fukutake, Katsuyuki ;

Key, Nigel S. ;

Portron, Agnes ;

Schmitt, Christophe ;

Podolak-Dawidziak, Maria ;

Bienz, Nives Selak ;

Hermans, Cedric ;

Campinha-Bacote, Avrita ;

Kiialainen, Anna ;

Peerlinck, Kathelijne ;

Levy, Gallia G. ;

Jimenez-Yuste, Victor .

LANCET HAEMATOLOGY, 2019, 6 (06) :E295-E305

[10] Every 2 Weeks or Every 4 Weeks Subcutaneous Injection of Emicizumab in Pediatric Patients with Severe Hemophilia a without Inhibitors: A Multi-Center, Open-Label Study in Japan (HOHOEMI Study) [J].

Shima, Midori ;

Nogami, Keiji ;

Nagami, Sayaka ;

Yoshida, Seitaro ;

Yoneyama, Koichiro ;

Ishiguro, Akira ;

Suzuki, Takashi ;

Taki, Masashi .

BLOOD, 2018, 132

← 1 2 →